Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Oncology Reports|April 11, 2017
Assessment of Th17 lymphocytes and cytokine IL‑17A in epithelial ovarian tumorsIzabela Winkler, Maria Pyszniak, Katarzyna Pogoda, et al.
Ginekologia Polska|July 18, 2014
[Carcinoma of the cervical stump--multicenter study]Tomasz Rechberger, Katarzyna Perzyło, Paweł Miotła, et al.
Immunobiology|November 1, 2020
An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentrationIzabela Winkler, Justyna Woś, Agnieszka Bojarska-Junak, et al.
European Urology|April 3, 2012
OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trialClare J Fowler, Stephen Auerbach, David Ginsberg, et al.
Ginekologia Polska|January 24, 2022
Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guidelines on the management of recurrent pelvic organ prolapseWlodzimierz Baranowski, Klaudia Stangel-Wojcikiewicz, Magdalena E Grzybowska, et al.
Ginekologia Polska|December 15, 2021
Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of stress urinary incontinence in womenKlaudia Stangel-Wojcikiewicz, Artur Rogowski, Tomasz Rechberger, et al.
Neurotoxicity Research|August 30, 2018
Blebbistatin, a Myosin II Inhibitor, Exerts Antidepressant-Like Activity and Suppresses Detrusor Overactivity in an Animal Model of Depression Coexisting with Overactive BladderAndrzej Wróbel, Urszula Doboszewska, Ewa Rechberger, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 20, 2020
Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2Kristina Gemzell-Danielsson, Oskari Heikinheimo, Janos Zatik, et al.
Ginekologia Polska|April 12, 2021
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of non-neurogenic overactive bladder syndrome in womenMagdalena E Grzybowska, Tomasz Rechberger, Andrzej Wrobel, et al.
European Urology|November 28, 2012
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trialVik Khullar, Gerard Amarenco, Javier C Angulo, et al.
Pageof 22